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Saudi Coronary Athero-Thrombotic Disease
(SAUDICAT): Intra-vascular ultra-sound study of
patients presenting with acute coronary syndrome
design and preliminary results
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Shiraz Mirza, Lamis Alshahrani, Lisette Okkels
Jensen
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lawand@yahoo.com (S. Lawand)
Background: Coronary Artery Disease in Saudis is
reaching epidemic levels. The extent of Coronary Ath-
ero-Thrombosis (CAT) is yet to be studied. We present
the design and preliminary results of IVUS project
intended for centres with IVUS capabilities in Saudi Ara-
bia. We aim at gathering clinical and quantitative IVUS
data.
Methods: 60 pts. IVUS studies at Prince Salman
Heart Center (PSHC), King Fahad Medical City reviewed.
40 of 105 runs analysed for Borderline Lesions 35 pts. Pre-
Runs (PR), 67 runs 25 pts. post stenting (PS). Initial anal-
ysis done at IVUS Core-Lab Odense University Hospital
Odense–Denmark, now available at PSHC. Each 1 mm
slice, had separate Luminal and External Elastic
Membrane (EEM) tracings, obtained 5 mm Proximal
and Distal to maximal Plaque Burden.
Results: 35 pts. (28 males, mean age 54 ± 18). 27 pts.
(77%) Diabetics. Forty IVUS borderline lesions runs
analysed.
12 pts. (34.29%) with recent ST Elevation Myocardial
Infarction (STEMI), 8 (22.86%) Non-STEMI (NSTEMI),
and 15 (42.85%) Unstable Angina (UA).
Non-Diabetics had larger Luminal, Vessel Diameters,
and Plaque Areas (P value: 0.048, 0.008 , 0.0088, 0.020),
Diabetics with NSTEMI had larger Plaque Areas and
Burden (P value: 0.0003, 0.0033). Vessels volumes non-
significantly different.
Conclusion: SAUDICAT, is the first national quanti-
tative IVUS study of CAT of Saudi pts. with ACS. Non
diabetics had larger vessels, diabetics with STEMI, and
NSTEMI had larger plaque areas and burdens.
We believe with the completion of this project, a Core-
Lab for IVUS studies can be established in Saudi Arabia
and the Middle East.
http://dx.doi:10.1016/j.jsha.2012.06.211
Impact of in-hospital recurrent ischemia event:
Findings from Gulf RACE-2
Abdullah Al-Saleh, Ahmed Hersi, Khalid Al-
Habib, A.A. Alsheikh-Ali, K. Sulaiman, H. Alfaleh
Background: Little in the literature is known about
the long term outcome of patients with acute coronary
syndrome (ACS) and in-hospital recurrent ischemic
event. Accordingly; our objectives were to determine
the baseline characteristics of patients, the predictors,
and the long term outcome of patients with recurrent
ischemia.
Methods: The population compromised 7930
enrolled in the second Gulf Registry of Acute Coronary
Events (Gulf RACE-2).
Results: Out of the 7930 ACS patients, 172 (2.2%) had
Re-MI during their hospital stay. Patients with Re-MI
were more likely to be older (mean age 59.12 ± 13.5 vs.
56.8 ± 12.4, P = 0.016), had significantly higher rate of
prior history of angina (48% vs. 38.2%, P = 0.006), and
hyperlipidemia (45.2% vs. 37.3%, P = 0.027) than patients
without Re-MI. On admission patients with Re-MI had
significantly higher HR, lower systolic BP, Killip class 4
and high GRACE risk score than those without Re-MI
(27.3% vs. 17.6%), (11% vs. 4.8%), (8.1% vs. 3.2%), and
(31.8% vs. 21.5%, P < 0.05 for all comparisons), respec-
tively. Patients with Re-MI had a higher rate of STEMI
on admission than patients without Re-MI (72.1% vs.
43.9%; P < 0.001). Re-MI patients were less likely to
receive Aspirin (94.8% vs. 98.5%, P = 0.002), beta blockers
(95.3% vs. 74.7%, P < 0.001), and Statin (87.2% vs. 94.9%,
P < 0.001) than patients without Re-MI. Coronary angio-
gram was less frequently performed on patients with
Re-MI than patients without Re-MI (30.8% vs. 32.5%,
P = 0.036). In hospital adverse events including HF, car-
diogenic shock, VT/VF were more frequent in the Re-
MI group than patients without Re-MI (44.2% vs.
12.4%), (25.6% vs. 5.3%), (7.6% vs. 2.7%; P < 0.001 for all
comparisons) respectively. In ACS patients with Re-MI
in-hospital, 30 days and 1 year were significantly higher
that patients without Re-MI (23.8% vs. 4.1%), (28.1% vs.
7.7%), and (31.6% vs. 12.1%; P < 0.001 for all comparisons),
respectively.
Conclusion: Recognizing patients at high risk of Re-
MI is important as modifying the risk factors, and manag-
ing the patient aggressively may reduce the incidence of
such events and the associated morbidity and mortality.
http://dx.doi:10.1016/j.jsha.2012.06.212
Social impact of Congenital Heart diseases in
Saudi families
Sulaiman S. Almesned, Abdulrahman A.
Almesned, Ali A. Al-Akhfash
Introduction: Chronic illness may result in a variety
of stressful outcomes, families of children with congenital
heart disease are not exception.
In Saudi Arabia, many public supporting groups for
families with chronically ill children like diabetics or can-
cer patients are active and giving a great deal of help but
unfortunately, non are available for families of children
with severe congenital heart disease.
Our study is an effort to put this issue in focus.
Objective: To evaluate the social impact on families
of patients with of congenital heart disease.
Design: Cross sectional survey.
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Setting: Pediatric cardiology outpatient department
at Prince Sultan Cardiac Center – Qassim.
Patients: Parents of 71 randomly selected children
with CHD of different severity.
Main outcome measures: The social impact on fam-
ily score.
Methods: The impact on family questionnaire of
Stein and Riessman was instituted. This questionnaire,
which determines the effects of a chronic illness on par-
ents and families, has been used to assess the impact of
CHD. It is based on four subscales assessing perceived
(1) financial burden; (2) familial/social impact; (3) per-
sonal strain; and (4) mastery. The first subscale contains
four statements. The second subscale contains nine state-
ments assessing social effects of CHD. The third subscale
has six statements relating to the personal stress imposed
by CHD on the parent. The third subscale has six state-
ments relating to the personal stress imposed by CHD
on the parent. The final subscale contains positively
phrased statements to assess the positive effects of the
child’s CHD on the parent’s feelings of control in his or
her life. The parent’s response is given as a number from
1 to 4, where 1 represents strong agreement, 2 predomi-
nant agreement, 3 weak partial agreement, and 4 strong
disagreement. The fourth subscale is reverse coded, so
that it is compatible with the other subscales to calculate
a final score where a low score corresponds to a high
impact. This score is then inverted so that a high score
is equivalent to a high impact. The questionnaire was
administered by a two Researchers. Patients were
divided into three groups according to the severity of
the CHD they do have (Mild, Moderate and Sever). Mild
CHD was defined as any CHD with no need for medical
or surgical management. Moderate CHD was defined as
a CHD which required surgical or cath intervention.
Severe CHD was defined as CHD with single ventricle
physiology who underwent Glenn or Fontan procedure,
as well as patients with dilated CMP taking more than
two cardiovascular medications. The mean impact on
family scores was compared among the different groups
by two sample t test analysis.
Results: Families of 71 children with severe CHD
were interrogated. The main age was 3.76 ± 3 years. 23
were males (32.4%) and 48 (67.6%) were females. Mild
CHD constitute 36.6%, moderate 29.6% and severe 33.8%.
Families of children with severe CHD had a signifi-
cantly higher impact on family score (mean of 62) than
families with mild and moderate CHD (mean of 48) P
value > .005.
Conclusion: Families of patients with severe CHD
have significant social impact because of their child ill-
ness. Supporting public groups in Saudi Arabia should
be initiated and encouraged.
http://dx.doi:10.1016/j.jsha.2012.06.213
Active fixation pacing leads in the distal coronary
venous system in patients with prosthetic tricus-
pid valve
Ahmad Fazli Abdul Aziz, Azlan Hussin, Surinder
Kaur, Tay Giat Sing, Zunida Ali, Noor Asyikin
Sahat, Razali Omar
Introduction: Permanent pacemaker implantations
in patients requiring ventricular pacing is usually accom-
plished by the placement of endocardial pacing lead in
the right ventricle. In the presence of prothestic tricuspid
valve, this method has the potential of causing complica-
tions to the lead or the prosthetic valve and thus not rec-
ommended. Pacing options for this group of patients
include epicardial lead implantation or the placement
of lead in the coronary sinus. We describe the use of
active fixation lead mechanism in the coronary sinus to
improve stability in this group of patients.
Methods: Between July 2010 until September 2011, we
implanted 4F active fixation leads (SelectSecure Model
3830, Medtronic, Minneapolis, MN, USA) in three patients
with prosthetic tricuspid valve who required ventricular
pacing. Active fixation leads were used in view of lead
instability with conventional coronary sinus pacing leads.
The lead was positioned and actively fixed at its optimal at
the distal coronary sinus. The performances of the leads
and its related complications were then monitored.
Results: The leads were successfully implanted in all
three patients. The peri implantation pacing parameters
were within acceptable limits with pacing thresholds of
2.3, 1.2 and 0.5 V, respectively and pacing impedances
of 1450, 817 and 1384X. Follow up interrogation revealed
stable pacing parameters. No immediate complications
were observed.
Conclusion: A 4F active fixation lead placement at
the distal coronary sinus to deliver left ventricular stimu-
lation in patients with prosthetic tricuspid valve showed
stable and consistent delivery of acceptable pacing
performances.
http://dx.doi:10.1016/j.jsha.2012.06.214
Assessment of left ventricular geometry, functions
and mass in patients with metabolic syndrome
Ahmed M. Sanad, Azza Z. El-Eraky, Mohamed A.
Oraby, Hanan M. Kamal
Background and aims: The frequent coexistence of
obesity, arterial hypertension, and lipid and carbohy-
drate disorders is well known. Although these conditions
have been identified as independent risk factors for
impaired left ventricular diastolic function, there is a
paucity of data on the dysfunction among patients with
metabolic syndrome (MS). The aim of this study was to
determine the impact of metabolic syndrome on left ven-
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